logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Marea Therapeutics Appoints Rebecca Juliano As Chief Development Officer and Max Zeiberg As Senior Vice President, Corporate Development

Dec 19, 2024•12 months ago

Position

Vice President of Corporate Development

Company

Marea Therapeutics

Max Zeiberg
San FranciscoTherapeuticsBiotechnology

Description

Marea Therapeutics, Inc announced the addition of Rebecca Juliano, PhD, as Chief Development Officer, and Max Zeiberg as Senior Vice President, Corporate Development.

Company Information

Company

Marea Therapeutics

Location

San Francisco, California, United States

About

Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases. The company’s lead program, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. Marea is led by a dynamic team of scientists and company builders with deep know-how and experience in cardiometabolic diseases, human genetics and adipocyte biology.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months